The Strategic Initiatives Program from the Barth Syndrome Foundation funds translational research to accelerate new therapies and interventions for Barth syndrome by overcoming key technical and regulatory barriers.
Funder: Barth Syndrome Foundation
Due Dates: Rolling
Funding Amounts: Flexible, milestone-based funding; amount and duration vary by project needs.
Summary: Accelerates the translation of promising research into therapies or interventions for Barth syndrome by addressing technical, regulatory, and financial barriers.
Key Information: Proposals are accepted on a rolling basis and must align with BSF’s strategic plan focus areas.
The Strategic Initiatives Program (SIP) from the Barth Syndrome Foundation is a targeted funding mechanism designed to advance research and development efforts specifically aimed at Barth syndrome. Unlike traditional seed grants, SIP focuses on accelerating the translation of scientific or clinical advancements into tangible therapies or interventions. The program addresses complex challenges—such as technical, regulatory, or financial barriers—that impede progress in the research pipeline. Funding is milestone-based, and BSF actively collaborates with project teams to ensure sustained momentum and impact for the Barth syndrome community. Projects funded through SIP are selected based on their alignment with the foundation’s strategic plan and their potential to bridge critical gaps in therapy or intervention development.